Vraylar 1.5 MG capsule 30S

Ended Awarded Last action

Contract number
SPE2DR26F4BFD
Awardee
Awarding agency
Obligated
$19,679

Award facts

Contract value 100% obligated
$19,679.38 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $19,679.38 delivery order to Amerisourcebergen Drug Corp on April 22, 2026, for Vraylar 1.5 mg capsule 30-count units, with an ultimate completion date of April 23, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., operates as a pharmaceutical distributor supplying brand-name and generic medications to the Department of Defense and federal healthcare systems under full-and-open competitive awards.

Quick answers

Who was awarded contract SPE2DR26F4BFD?

SPE2DR26F4BFD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 22, 2026.

How much is contract SPE2DR26F4BFD worth?

The government has obligated $19,679 on SPE2DR26F4BFD.

Is contract SPE2DR26F4BFD an order under another contract?

Yes. SPE2DR26F4BFD is a delivery order under SPE2DR25D2104, an indefinite delivery contract.

Was contract SPE2DR26F4BFD competed?

The extent of competition for SPE2DR26F4BFD was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award